Evidence map›Paper›PMID 32334633›Full record

ArticleJournal of orthopaedic surgery and research2020

PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.

Hai-Ping Zhang, Zi-Liang Yu, Bing-Bing Wu, Fa-Rui Sun

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Network pharmacology reveals thatGenes & diseases · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. CD36International journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Hai-Ping ZhangDepartment of Orthopedics, Second Affiliated Hospital of Nantong University, Nantong, 226000, Jiangsu, People's Republic of China.
Zi-Liang YuDepartment of Orthopedics, Second Affiliated Hospital of Nantong University, Nantong, 226000, Jiangsu, People's Republic of China.
Bing-Bing WuDepartment of Orthopedics, Second Affiliated Hospital of Nantong University, Nantong, 226000, Jiangsu, People's Republic of China.
Fa-Rui SunDepartment of Orthopedics, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Tianjin Rd, Huangshi, 435000, Hubei Province, People's Republic of China. zhuzouxie19890118@163.com.
Affiliated Hospital of Nantong University · CNHuangshi Central Hospital · CNNantong University · CNSecond Affiliated Hospital of Nantong University

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis article reports the effects of proenkephalin (PENK) on osteosarcoma (OS) cell migration.

methodsA Gene Expression Omnibus (GEO) dataset was used to identify differentially expressed genes (DEGs) in OS tumor samples and normal human osteoblasts. Tumor tissue and adjacent normal tissue were collected from 40 OS patients. MG63 cells were transfected with si-PENK. Transwell migration assays and wound healing assays were performed to compare the effect of PENK on migration. Moreover, LY294002 was used to identify the potential mechanism. Gene expression was examined via qRT-PCR and Western blotting.

resultsBioinformatic analysis revealed that PENK was downregulated in OS tumor samples compared with normal human osteoblasts. Moreover, PENK was identified as the hub gene of the DEGs. The PI3K/Akt signaling pathway was significantly enriched in the DEGs. Moreover, PENK was downregulated in OS and MG63 cells compared with the corresponding control cells. Silencing PENK promoted MG63 cell migration; however, treatment with LY294002 partially attenuated PENK silencing-induced OS cell migration.

conclusionPENK inhibits OS cell migration by activating the PI3K/Akt signaling pathway.

Indexed as

Cell MovementSignal TransductionAdultBlotting, WesternBone NeoplasmsCell Line, TumorEnkephalinsFemaleGene Expression Regulation, NeoplasticHumansMaleOsteoblastsOsteosarcomaPhosphatidylinositol 3-KinasesProtein PrecursorsProto-Oncogene Proteins c-aktEnkephalinsPhosphatidylinositol 3-KinasesproenkephalinProtein PrecursorsProto-Oncogene Proteins c-aktAktMigrationOsteosarcomaPENKPI3K

Identifiers

PMID32334633
PMCPMC7183709
OpenAlexW3020092898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.